150 related articles for article (PubMed ID: 1399377)
21. [Well-controlled comparative study on aztreonam and cefoperazone in the treatment of complicated urinary tract infections].
Ohmori H; Kumon H; Kumamoto Y; Sakai S; Niijima T; Kishi H; Ohkoshi M; Kawamura N; Naide Y; Nishiura T
Jpn J Antibiot; 1986 Jan; 39(1):24-56. PubMed ID: 3517407
[TBL] [Abstract][Full Text] [Related]
22. Aztreonam therapy in children with febrile neutropenia: a randomized trial of aztreonam plus flucloxacillin versus piperacillin plus gentamicin.
Heney D; Lewis IJ; Ghoneim AT; Chisholm P; Bailey CC
J Antimicrob Chemother; 1991 Jul; 28(1):117-29. PubMed ID: 1769930
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
Clergeot A; Steru D; Rosset MA; Carbon C
Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
[TBL] [Abstract][Full Text] [Related]
24. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
Swabb EA; Jenkins SA; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
[TBL] [Abstract][Full Text] [Related]
25. Aztreonam in the treatment of urinary tract infections: a multicenter trial.
Martelli A; Cortecchia V; Ventriglia L
Chemotherapy; 1989; 35 Suppl 1():8-14. PubMed ID: 2659294
[TBL] [Abstract][Full Text] [Related]
26. Treatment of complicated urinary tract infections. Comparative study of sisomicin and gentamicin.
Madsen PO; Kjaer TB; Mosegaard A
Urology; 1977 Jun; 9(6):635-8. PubMed ID: 329522
[TBL] [Abstract][Full Text] [Related]
27. Aztreonam.
Cunha BA
Urology; 1993 Mar; 41(3):249-58. PubMed ID: 8442309
[TBL] [Abstract][Full Text] [Related]
28. Comparison of aztreonam against other antibiotics used in urinary tract infections.
Khan MT; Shah SH
J Ayub Med Coll Abbottabad; 2001; 13(4):22-4. PubMed ID: 11873424
[TBL] [Abstract][Full Text] [Related]
29. Gentamicin and gentamicin C1 in the treatment of complicated urinary tract infections: comparative study of efficacy, tolerance, and pharmacokinetics.
Mosegaard A; Welling PG; Madsen PO
Antimicrob Agents Chemother; 1975 Mar; 7(3):328-32. PubMed ID: 1137386
[TBL] [Abstract][Full Text] [Related]
30. A comparison of aztreonam and two regimens of gentamicin in a rabbit model of intra-amniotic infection and sepsis.
McDuffie RS; Heddleston LN; Blanton SJ; Gibbs RS
J Soc Gynecol Investig; 1995; 2(1):23-5. PubMed ID: 9420844
[TBL] [Abstract][Full Text] [Related]
31. Multicenter study of aztreonam in the prophylaxis of colorectal, gynecologic and urologic surgery.
Mozzillo N; Dionigi R; Ventriglia L
Chemotherapy; 1989; 35 Suppl 1():58-71. PubMed ID: 2659291
[TBL] [Abstract][Full Text] [Related]
32. [An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
Martelli A; Cortecchia V; Ventriglia L
Clin Ter; 1988 May; 125(3):191-201. PubMed ID: 2973940
[No Abstract] [Full Text] [Related]
33. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
Rabinad E; Bosch-Perez A
Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
[TBL] [Abstract][Full Text] [Related]
34. One bolus dose of gentamicin and early oral therapy versus cefotaxime and subsequent oral therapy in the treatment of febrile urinary tract infection.
Sundman K; Arneborn P; Blad L; Sjöberg L; Vikerfors T
Eur J Clin Microbiol Infect Dis; 1997 Jun; 16(6):455-8. PubMed ID: 9248749
[TBL] [Abstract][Full Text] [Related]
35. Comparative clinical evaluation of aztreonam versus aminoglycosides in gram-negative septicaemia.
Gudiol F; Pallarés R; Ariza X; Fernández-Viladrich P; Rufi G; Liñares J
J Antimicrob Chemother; 1986 May; 17(5):661-71. PubMed ID: 3722035
[TBL] [Abstract][Full Text] [Related]
36. Aztreonam versus gentamicin in short-term prophylaxis in biliary and gastric surgery.
Puleo S; Li Destri G; Russello D; Blandino G; Nicoletti G; Rodolico G
J Chemother; 1989 Jul; 1(4 Suppl):992-3. PubMed ID: 16312738
[No Abstract] [Full Text] [Related]
37. [Aztreonam as monotherapy in urinary tract infections with a systemic repercussion in patients with a relative contraindication for the use of aminoglycosides].
Pedrajas JM; Pieltain R; Mesa N; Ramón P; García C; Pontes JC; Fernández-Cruz A
Rev Clin Esp; 1993 Apr; 192(6):256-9. PubMed ID: 8497718
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
39. [Clinical reevaluation of aztreonam (AZT) on urinary tract infections].
Kohri K; Kurita T; Sakaguti H; Kadowaki T; Iguti M; Kanda H; Nagi N; Kataoka K; Kawamura M; Mitsubayashi S
Hinyokika Kiyo; 1989 Apr; 35(4):711-6. PubMed ID: 2660527
[TBL] [Abstract][Full Text] [Related]
40. Aztreonam.
Clark P
Obstet Gynecol Clin North Am; 1992 Sep; 19(3):519-28. PubMed ID: 1436929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
